[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370418-105":59,"doc-detail-370418-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-novel-mechanism-for-a-to-i-rna-edited-cyp1a1-in-promoting-cancer-progression-in-nsclc","A novel mechanism for A-to-I RNA-edited CYP1A1 in promoting cancer progression in NSCLC","","Lung cancer is a leading cause of cancer mortality, and non-small cell lung cancer (NSCLC) develops through layered genetic and epigenetic alterations. A-to-I RNA editing is a widespread posttranscriptional epigenetic modification, yet its role as a driver in NSCLC progression remains unclear. The study validates CYP1A1 I462V editing in patients, evaluates ADAR1-regulated editing effects on NSCLC growth and metastasis, and links CYP1A1 I462V editing to PI3K-AKT signaling and oxidative-stress responses.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-novel-mechanism-for-a-to-i-rna-edited-cyp1a1-in-promoting-cancer-progression-in-nsclc/370418/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-novel-mechanism-for-a-to-i-rna-edited-cyp1a1-in-promoting-cancer-progression-in-nsclc/370418.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main question addressed by this study in NSCLC?","Question",{"text":112,"@type":113},"How A-to-I RNA editing of CYP1A1 contributes to cancer progression in NSCLC, including the underlying signaling and oxidative-stress mechanisms.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the CYP1A1 I462V RNA editing event validated?",{"text":117,"@type":113},"Sanger sequencing was used to validate the CYP1A1_I462V RNA editing event in NSCLC patients.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism does the study propose connecting CYP1A1 editing to cancer progression?",{"text":121,"@type":113},"ADAR1-regulated CYP1A1 A-to-I RNA editing induces HO-1 expression via PI3K/Akt-dependent activation, promotes nuclear translocation of HO-1, and helps NSCLC cells resist oxidant stress.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370418,1790220091,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Wang et al.  \nCellular & Molecular Biology Letters (2025) 30:40 [https://doi.org/10.1186/s11658-025-00718-6](https://doi.org/10.1186/s11658-025-00718-6)  \nCellular & Molecular Biology Letters  \nRESEARCH ARTICLE Open Access  \nA novel mechanism for A-to-I RNA-edited CYP1A1 in promoting cancer progression in NSCLC  \nZhipeng Wang1†, Yan Wu3†, Ziqi Ding1, Xinru Xiao1, Yanhua Huang1, Zhiguang Liu1 and Qian Zhang1,2*  \n\n| †Zhipeng Wang andYan Wu have contributed equally to this work. |\n| --- |\n| *Correspondence: [qianzhang@njmu.edu.cn](qianzhang@njmu.edu.cn) |\n\n1 Department of Respiratory and Critical Care Medicine, the Second People’s Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University, Changzhou 213164, China  \n2 Changzhou Medical Center, Nanjing Medical University, Changzhou 213164, China  \n3 State Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic and Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China  \nAbstract  \nBackground: Lung cancer is the most frequently diagnosed malignancy and the leading cause of cancer-related mortality worldwide. Similar to other solid tumors, the development of non-small cell lung cancer (NSCLC) is believed to be a multistep process involving the accumulation of genetic and epigenetic alterations. A-to-I  \nRNA editing is a widespread posttranscriptional epigenetic modification that confers specific nucleotide changes in selected RNA transcripts and plays a critical role in the pathogenesis of many human cancers. However, the mechanisms underlying A-to-I RNA editing that act as a potential driver in the pathogenesis of NSCLC progression remain incompletely elucidated.  \nMethods: Sanger sequencing was performed to validate the CYP1A1_I462V RNA editing event in NSCLC patients. In vitro and in vivo experiments were used to assess the effects of an ADAR1-regulated CYP1A1 and its editing on NSCLC cell growth and metastasis. The crosstalk between CYP1A1_I462V RNA editing and PI3K-AKT signaling was analyzed using RNA sequencing and molecular methods. The functional role of CYP1A1_I462V in the response to oxidative stress was verified through proteomics analysis, co-IP assay, and immunofluorescence assay.  \nResults: Sanger sequencing analysis identified an increased A-to-I RNA editing  \nratio of CYP1A1 in NSCLC specimens. This specific RNA editing, regulated by ADAR1, resulted in gain-of-function phenotypes characterized by enhanced tumor progression and more aggressive behavior. The edited form induced the expression of heme oxygenase-1 (HO-1) via PI3K/Akt-dependent activation compared with the wild-type CYP1A1, which led to an enhanced interaction with CYP1A1, thereby promoting the translocation of abundant HO-1 into the nucleus to resist oxidant stress in NSCLC cells.  \nConclusions: Our findings highlight that the I462V A-to-I RNA editing event of CYP1A1 drives pulmonary carcinogenesis through inhibiting oxidative stress and suggest that the CYP1A1-HO-1-PI3K/Akt axis may be a potential therapeutic target for NSCLC.  \nKeywords: A-to-I RNA editing, CYP1A1 gene, Non-small-cell lung cancer, Heme oxygenase-1  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copy","cbCaikjPrInih2An","https://ap.wps.com/l/cbCaikjPrInih2An","pdf",6090600,21,"English","# Background\n# Methods\n# Results\n# Conclusions\n# Graphical Abstract - Background","[{\"question\":\"What is the main question addressed by this study in NSCLC?\",\"answer\":\"How A-to-I RNA editing of CYP1A1 contributes to cancer progression in NSCLC, including the underlying signaling and oxidative-stress mechanisms.\"},{\"question\":\"How was the CYP1A1 I462V RNA editing event validated?\",\"answer\":\"Sanger sequencing was used to validate the CYP1A1_I462V RNA editing event in NSCLC patients.\"},{\"question\":\"What mechanism does the study propose connecting CYP1A1 editing to cancer progression?\",\"answer\":\"ADAR1-regulated CYP1A1 A-to-I RNA editing induces HO-1 expression via PI3K/Akt-dependent activation, promotes nuclear translocation of HO-1, and helps NSCLC cells resist oxidant stress.\"}]","A novel mechanism for A-to-I RNA-edited CYP1A1 in promoting cancer progression in NSCLC | PDF",1790188423,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68a20844af704725de4bb6473f39b7ce.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6441ede6e2e274c91d2113b59c7052ff.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2cf47bb56e3d824362260bc0540974e8.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/43e9f4c760f43610127d2485047c4d96.webp",980,1301]